Johnson & Johnson (NYSE:JNJ) is one of the best companies in the US in terms of returning capital to shareholders. Management makes buying back stock and paying dividends a collective priority and the formula has worked; dividend investors in particular can't get enough of JNJ's capital returns. The dividend is a big piece of it but the buyback consumes about the same amount of money as the dividend on average, making the effectiveness of it a priority for holders as well. In this article, I'll take a look at what JNJ has spent buying back stock and what it has to show for it.
